No Data
No Data
Express News | Summary of Shareholding announcements | The controlling Shareholder and Director of this company plan to reduce their holdings by 4%.
Northeast Pharmaceutical Group (000597.SZ): The concerted parties of the controlling Shareholder plan to increase their Shareholding by 0.075 billion yuan to -0.15 billion yuan in the company's shares.
Glory Financial reported on December 10th that Northeast Pharmaceutical Group (000597.SZ) announced that the company's controlling Shareholder, Liaoning China Fangda Group Industrial Co., Ltd. (referred to as "China Fangda Group"), and its concerted party, Jiangxi Fangda Steel Group Co., Ltd. (hereinafter referred to as "Fangda Steel/Shareholding entity"), plan to increase their shareholding in the company within six months from the date of the announcement, with a planned increase of no less than 75 million yuan and no more than 150 million yuan. The funds for this increase will come from Fangda Steel's own funds and special loans.
Express News | Northeast Pharmaceutical Group: Fangda Steel intends to increase shareholding by 75 million to 0.15 billion.
Express News | Northeast Pharmaceutical Group: The Supreme Court rejects the application for retrial of the debt rights transfer contract dispute.
Express News | Nearly 20 A-share listed companies disclosed the latest M&A restructuring announcements this week. Western Securities intends to acquire 64.6% stake in Guorong Securities for 3.825 billion yuan.
Northeast Pharmaceutical Group Acquiring 70% Stake in Dingcheng Peptide Source; Shares Up 10%
No Data